Target intelligence / Profile preview

Zinc finger protein 430 (ZNF430)

Target
ZNF430
Molecular classification
Transcription factor, DNA-binding protein, Zinc finger protein (C2H2-type)
01

Overview

Zinc finger protein 430 is a DNA-binding transcription factor of the C2H2-type zinc finger protein family, predicted to regulate gene expression through sequence-specific binding to RNA polymerase II cis-regulatory regions and DNA, with a role in substantia nigra development and possible involvement in cancer[1][2][3][4]. It is a nuclear protein, part of the most prevalent class of zinc finger-containing transcription factors, which are central to gene regulatory networks and implicated in both normal development and tumorigenesis[1][2][3][4]. No evidence currently indicates it is directly druggable, nor are there known drugs or clinical biomarkers specifically targeting ZNF430[1].

Other names
ZNF430FLJ13659zinc finger protein 430
02

Biological functions

Transcriptional regulationDNA bindingRegulation of gene expressionInvolved in substantia nigra development
03

Disease associations

Cancer (diseases associated: breast leiomyosarcoma, breast liposarcoma)

Beyond the preview

Go deeper on Zinc finger protein 430 (ZNF430).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger protein 430 (ZNF430).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call